Abstract | BACKGROUND: METHODS: Wistar-Furth rat hearts were grafted to Lewis rats. Activated T-cell proliferation, viability, and interleukin-2 expression were determined. RESULTS: Mean survival in days were: saline 7.12+/-0.64, FDP 350 mg/kg perioperatively 13.5+/-1.4, FDP 350 mg/kg twice daily 11.4+/-0.75, CsA 2.5 mg/kg daily 12+/-0.81, CsA 5.0 mg/kg daily 12.4+/-0.81, CsA 2.5 mg/kg + FDP 350 mg/kg twice daily 17.6+/-0.4, and CsA 5 mg/kg + FDP 350 mg/kg twice daily 28.2+/-0.97. FDP maximally inhibits T-cell proliferation and concomitantly increases cell viability at 5,000 to 500 microg/mL, whereas CsA inhibits at 500 ng/mL. FDP completely inhibited interleukin-2 expression at 5,000 to 500 microg/mL, whereas CsA partially inhibited at 50 to 500 ng/mL. CONCLUSION:
FDP + CsA prolongs cardiac survival and FDP inhibits T-cell proliferation.
|
Authors | Angel K Markov, Thomas S Rayburn, David S Talton, Donald E Netherland, Charles Moore, Bobby Heath, Hari H Cohly |
Journal | Transplantation
(Transplantation)
Vol. 74
Issue 11
Pg. 1651-4
(Dec 15 2002)
ISSN: 0041-1337 [Print] United States |
PMID | 12490806
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Cardiovascular Agents
- Fructosediphosphates
- Immunosuppressive Agents
- Interleukin-2
- Cyclosporine
- fructose-1,6-diphosphate
|
Topics |
- Animals
- Cardiovascular Agents
(therapeutic use)
- Cell Division
(drug effects)
- Cyclosporine
(therapeutic use)
- Drug Therapy, Combination
- Fructosediphosphates
(therapeutic use)
- Graft Survival
(drug effects)
- Heart Transplantation
- Immunosuppressive Agents
(therapeutic use)
- Interleukin-2
(antagonists & inhibitors)
- Rats
- Rats, Inbred Lew
- Rats, Inbred WF
- Rats, Sprague-Dawley
- T-Lymphocytes
(pathology)
- Transplantation, Heterotopic
|